Cargando…

The impact of COVID-19 on global tuberculosis control

Detalles Bibliográficos
Autores principales:	Lipman, Marc, McQuaid, C. Finn, Abubakar, Ibrahim, Khan, Mishal, Kranzer, Katharina, McHugh, Timothy D., Padmapriyadarsini, Chandrasekaran, Rangaka, Molebogeng X., Stoker, Neil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354050/ https://www.ncbi.nlm.nih.gov/pubmed/34380784 http://dx.doi.org/10.4103/ijmr.IJMR_326_21

Ejemplares similares

Ending the tuberculosis syndemic: is COVID-19 the (in)convenient scapegoat for poor progress?
por: Rangaka, Molebogeng X, et al.
Publicado: (2022)

The Risk of Falsely Declaring Noninferiority of Novel Latent Tuberculosis Treatment in Large Trials
por: Abubakar, Ibrahim, et al.
Publicado: (2020)

Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis
por: Gupta, Rishi K, et al.
Publicado: (2020)

World TB Day 2016: an interview with leading experts in tuberculosis research
por: Phillips, Patrick P. J., et al.
Publicado: (2016)

World TB Day 2018: The Challenge of Drug Resistant Tuberculosis
por: Gupta-Wright, Ankur, et al.
Publicado: (2018)

Uniting to end the TB epidemic: advances in disease control from prevention to better diagnosis and treatment
por: Abubakar, Ibrahim, et al.
Publicado: (2016)

Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling
por: Knight, Gwenan M, et al.
Publicado: (2019)

Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts
por: Chakaya, Jeremiah, et al.
Publicado: (2021)

Tuberculosis Antigen-Specific T-Cell Responses During the First 6 Months of Antiretroviral Treatment
por: Riou, Catherine, et al.
Publicado: (2020)

Risk for development of active tuberculosis in patients with chronic airway disease—a systematic review of evidence
por: Hamada, Yohhei, et al.
Publicado: (2021)

A Systematic Review on the Safety of Mycobacterium tuberculosis–Specific Antigen–Based Skin Tests for Tuberculosis Infection Compared With Tuberculin Skin Tests
por: Hamada, Yohhei, et al.
Publicado: (2023)

Exploring a combined biomarker for tuberculosis treatment response: protocol for a prospective observational cohort study
por: Kloprogge, Frank, et al.
Publicado: (2021)

The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges
por: Naidoo, Pren, et al.
Publicado: (2017)

The cascade of care for latent tuberculosis infection in congregate settings: A national cohort analysis, Korea, 2017–2018
por: Min, Jinsoo, et al.
Publicado: (2022)

Reducing the risk of tuberculosis transmission for HCWs in high incidence settings
por: Paleckyte, Ana, et al.
Publicado: (2021)

Emergence of phenotypic and genotypic antimicrobial resistance in Mycobacterium tuberculosis
por: Kloprogge, Frank, et al.
Publicado: (2022)

Altered Ratio of IFN-γ/IL-10 in Patients with Drug Resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory Syndrome
por: Skolimowska, Keira H., et al.
Publicado: (2012)

Effect of study design and setting on tuberculosis clustering estimates using Mycobacterial Interspersed Repetitive Units-Variable Number Tandem Repeats (MIRU-VNTR): a systematic review
por: Mears, Jessica, et al.
Publicado: (2015)

The global impact of household contact management for children on multidrug-resistant and rifampicin-resistant tuberculosis cases, deaths, and health-system costs in 2019: a modelling study
por: Dodd, Peter J, et al.
Publicado: (2022)

Global distribution and diversity of marine euendolithic cyanobacteria
por: Wyness, Adam J., et al.
Publicado: (2022)

Malnutrition: Modulator of Immune Responses in Tuberculosis
por: Chandrasekaran, Padmapriyadarsini, et al.
Publicado: (2017)

Updating age-specific contact structures to match evolving demography in a dynamic mathematical model of tuberculosis vaccination
por: Weerasuriya, Chathika Krishan, et al.
Publicado: (2022)

C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study
por: Mendelson, Fiona, et al.
Publicado: (2018)

Genetic variation in Mycobacterium tuberculosis isolates from a London outbreak associated with isoniazid resistance
por: Satta, Giovanni, et al.
Publicado: (2016)

Current trends and intricacies in the management of HIV-associated pulmonary tuberculosis
por: Gopalan, Narendran, et al.
Publicado: (2016)

Affordability of Adult Tuberculosis Vaccination in India and China: A Dynamic Transmission Model-Based Analysis
por: Weerasuriya, Chathika Krishan, et al.
Publicado: (2021)

A user-centred design framework for mHealth
por: Farao, Jaydon, et al.
Publicado: (2020)

Population tailored modification of tuberculosis specific interferon-gamma release assay
por: Horvati, Kata, et al.
Publicado: (2016)

The potential impact of COVID-19-related disruption on tuberculosis burden
por: McQuaid, C. Finn, et al.
Publicado: (2020)

Role of the Interleukin 10 Family of Cytokines in Patients With Immune Reconstitution Inflammatory Syndrome Associated With HIV Infection and Tuberculosis
por: Tadokera, Rebecca, et al.
Publicado: (2013)

Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population
por: Ige, Fehintola, et al.
Publicado: (2021)

Git in Practice
por: McQuaid, Mike
Publicado: (2014)

EXPLORING HEALTHCARE WORKERS' GERIATRIC EDUCATION AND SUBSEQUENT COMMUNICATION WITH OLDER ADULTS
por: McQuaid, Tina
Publicado: (2022)

A Rapid and Sensitive Diagnostic Screening Assay for Detection of Mycobacteria Including Mycobacterium tuberculosis Directly from Sputum without Extraction
por: Cross, Lisa Jane, et al.
Publicado: (2015)

Pneumocystis jirovecii Pneumonia in Tropical and Low and Middle Income Countries: A Systematic Review and Meta-Regression
por: Lowe, David M., et al.
Publicado: (2013)

Plasma Biomarkers to Detect Prevalent or Predict Progressive Tuberculosis Associated With Human Immunodeficiency Virus–1
por: Lesosky, Maia, et al.
Publicado: (2019)

Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trial
por: Witney, Adam A., et al.
Publicado: (2017)

Are mRNA based transcriptomic signatures ready for diagnosing tuberculosis in the clinic? - A review of evidence and the technological landscape
por: Hamada, Yohhei, et al.
Publicado: (2022)

Mitigating the impact of COVID-19 on tuberculosis and HIV services: A cross-sectional survey of 669 health professionals in 64 low and middle-income countries
por: Khan, Mishal S., et al.
Publicado: (2021)

Inequalities in the impact of COVID-19-associated disruptions on tuberculosis diagnosis by age and sex in 45 high TB burden countries
por: McQuaid, C. Finn, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_c8s2dth8pv3on1lt0r2o84ubrd